ZIM
MLAB icon

Zacks Investment Management’s Mesa Laboratories MLAB Stock Holding History

Zacks Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,950
Closed -$430K – 736
2024
Q2 		$430K Sell
4,950
-18,299
-79% -$1.92M ﹤0.01% 465
2024
Q1 		$2.55M Buy
23,249
+7,064
+44% +$712K 0.03% 283
2023
Q4 		$1.7M Buy
+16,185
New +$1.58M 0.02% 311

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zacks Investment Management's MLAB Position: Q3 2024 in Review

Zacks Investment Management sold out of Mesa Laboratories (MLAB) in Q3 2024, closing a stake of 4,950 shares — an estimated $430K sold.

Zacks Investment Management first reported a position in MLAB in Q4 2023 and held it in 3 quarters. The position peaked at $2.55M in Q1 2024. 166 funds tracked by Wall St. Rank hold MLAB as of Q3 2024.

  • Zacks Investment Management reported no remaining Mesa Laboratories position as of Q3 2024 after selling out during the quarter.
  • Zacks Investment Management sold 4,950 Mesa Laboratories shares in Q3 2024, an estimated $430K.
  • Zacks Investment Management first reported a position in Mesa Laboratories in Q4 2023 and held it in 3 quarters.
  • Zacks Investment Management's Mesa Laboratories position peaked at $2.55M in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2024.

Based on Zacks Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.